TuHURA Biosciences (HURA) investor relations material

Executive summary

• The annual meeting will be held virtually on August 18, 2026, with six key proposals up for shareholder vote, including director elections, approval of share issuance, executive compensation, vote frequency, auditor ratification, and adjournment authority.

• Shareholders of record as of June 26, 2026, are entitled to vote, with a quorum set at one-third of outstanding shares.

• The board unanimously recommends voting in favor of all proposals.

Voting matters and shareholder proposals

• Proposal 1: Elect six directors to serve until the 2027 annual meeting.

• Proposal 2: Approve issuance of 1,878,287 shares to Parkview Holdings One LLC under a fee agreement, as required by Nasdaq rules.

• Proposal 3: Advisory vote on executive compensation (say-on-pay).

• Proposal 4: Advisory vote on frequency of future say-on-pay votes, with board recommending every three years.

• Proposal 5: Ratify Cherry Bekaert LLP as independent auditor for 2026.

• Proposal 6: Authorize adjournment of the meeting if necessary to solicit additional proxies.

Board of directors and corporate governance

• Board consists of six members, with a majority qualifying as independent under Nasdaq rules.

• Committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and independent membership.

• Board leadership separates the roles of Chairman and President/CEO.

• Code of Ethics and Insider Trading Policy are in place for directors, officers, and employees.